This was an eventful week for the hashish business.
On Monday, Tilray, Inc. (NASDAQ:TLRY) and Aphria, Inc. (NASDAQ:APHA) closed their merger after months of negotiations, creating an organization with a mixed market cap of $3.3 billion. Benzinga spoke with Irwin Simon, CEO of the brand new mixed firm.
Try the video beneath:
Following the merger, Jefferies upgraded the ranking for Tilray from Underperform to Purchase, whereas elevating the worth goal from $4.77 to $23.
Jazz Prescription drugs (NASDAQ:JAZZ) finalized its acquisition of GW Prescription drugs plc. (NASDAQ:GWPH), the producer of the FDA‑authorized prescription cannabidiol drug Epidiolex, for $7.2 billion or $6.7 billion web of GW Pharma’s money.
In the meantime, Ascend Wellness Holdings (CSE:AAWH) began buying and selling on the Canadian Securities alternate following a elevate of roughly $80 million via an preliminary public providing of roughly 10 million shares of its Class A standard inventory at $8 per share.